Diabetes, Metabolism & Endocrinologists near Paramus, NJ

Biography: Adi Cohen, MD, MHS is a Professor of Medicine at Columbia University Irving Medical Center and is Director of the Early-Onset Osteoporosis Center within the Metabolic Bone Diseases Program in the Division of Endocrinology.Dr. Cohen received her medical training at New York University School of Medicine and completed a fellowship in Endocrinology at Columbia University Medical Center, as well as a fellowship in Women's Health at Duke University and the Durham VA Medical Center. She has obtained a Master's Degree in Health Sciences (Clinical Research) through the Duke Clinical Research Institute. Dr. Cohen has conducted multiple studies to investigate pathogenesis of early-onset osteoporosis and treatment options for affected patients. Her current research focuses on osteoporosis in premenopausal women, pregnancy and lactation associated osteoporosis, relationships between body composition and bone metabolism, and the use of imaging tools for the noninvasive assessment of bone microstructure. Dr. Cohen's clinical practice, within the Metabolic Bone Diseases Program and the Early-Onset Osteoporosis Center in the Division of Endocrinology at CUIMC, builds upon knowledge acquired through ongoing research to provide individualized comprehensive clinical evaluation and personalized treatment plans for patients with osteoporosis.

Biography: Patricia Vuguin, MD, MSc, is Associate Professor of Pediatrics and Director of the Pediatric Endocrine Fellowship Program at Columbia University Medical Center (CUMC). She is also Medical Director of the Pediatric Thyroid Center at CUMC and NewYork-Presbyterian/Morgan Stanley Children's Hospital. Her expertise includes thyroid disease, metabolic syndrome, glucose metabolism, growth, puberty and disorders of puberty, and fetal programming of adult disease. Dr. Vuguin is an accomplished clinician, researcher, and educator. She is fluent in Spanish and English and empathetic to the medical needs of New York's Hispanic community. In her leadership role for the Pediatric Thyroid Center, she collaborates with a multidisciplinary team of specialists to care for children and adolescents with thyroid disorders, such as thyroid nodules and papillary thyroid cancer. In addition, Dr. Vuguin was the recipient of K08 and R21 awards from the National Institutes of Health (NIH), independent grants from pharmaceutical companies, and funding from the Juvenile Diabetes Research Foundation. She has published more than 50 peer-reviewed articles in research journals; presented her research findings at national and international meetings; and is an active member of the Pediatric Endocrine Society and the Society of Pediatric Research. Dr. Vuguin also completed a Master of Science Training Program in Clinical Research, an NIH-funded program offered by the Department of Epidemiology and Biostatistics at Albert Einstein College of Medicine. Prior to Columbia, Dr. Vuguin provided clinical care at Jacobi Medical Center, Montefiore Medical Center, and North Shore-Long Island Jewish (LIJ) Health System (now Northwell Health). She is a member of the SuperDoctors ® list and received an Outstanding Teacher Award from North Shore-LIJ Health System. The American Medical Association's Board of Trustees also selected her to serve on the Accreditation Council for Graduate Medical Education Review Committee for Pediatrics.

Biography: Dr. Kristen Williams, MD is an Endocrinology, Diabetes /amp Metabolism Specialist who practices in New York, NY. Dr. Kristen Williams, MD is affiliated with Newyork-Presbyterian/Columbia University Medical Center and Newyork-Presbyterian/Morgan Stanley Children's Hospital.

Biography: Dr. Reid is an Assistant Professor of Clinical Medicine at the College of Physicians and Surgeons, Columbia University in the Division of Endocrinology, and the Clinical Medical Educator at the Columbia University Institute of Human Nutrition. She completed her medical training at Albert Einstein College of Medicine, followed by an internship and residency in Internal Medicine at Montefiore Medical Center-Albert Einstein College of Medicine. After her residency, she spent a year as a Research Fellow and then completed her fellowship training in Endocrinology, Diabetes and Metabolism, both at the College of Physicians and Surgeons, Columbia University. Dr. Reid is board-certified in Internal Medicine and Endocrinology. During her fellowship, her research focused on acromegaly. She received an Endocrine Fellows Foundation Award as well as an NIH supplemental grant to investigate the endothelial function of patients with acromegaly. Her current research focuses on obesity and changes in hormones and medical co-morbidities in patients undergoing bariatric surgery. She currently treats patients at the Columbia University Weight Control Center.

Biography: Dr. Heidi Guzman, MD is an Endocrinology, Diabetes /amp Metabolism Specialist who practices in New York, NY. She has been practicing for 10 years. Dr. Heidi Guzman, MD is affiliated with Newyork-Presbyterian/Columbia University Medical Center.

Biography: Dr. Oberfield, a professor of pediatrics, has been the director of the Division of Pediatric Endocrinology, Diabetes, and Metabolism at Columbia University Irving Medical Center since 2004. Throughout her career, Dr. Oberfield has been dedicated to educating the next generation of pediatric endocrinology sub-specialists. She was for many years director of the fellowship training program in pediatric endocrinology, and is currently associate program director. Since 2005 she has been the principal investigator of a T32 training grant in pediatric endocrinology from the NIH National Institute of Diabetes, Digestive, and Kidney Diseases, one of only a handful of such programs in the country. Since 1998, she has mentored more than 35 fellows and more than 30 pre-doctoral students including Endocrine Society, DERC, and Doris Duke summer fellows. From 2021-2022 Dr. Oberfield served as president of the Lawson Wilkins Pediatric Endocrine Society (PES), an international organization of more than 1,300 members, that provides resources for healthcare professionals and trainees and affords educational support for patients and families affected by disorders of the thyroid, adrenal, and pituitary glands; growth disturbances; and conditions of bone metabolism and diabetes. Her priorities as president, she says, were "to maintain and expand the relevance of bench, translational and clinical researcher as well as the importance of the practicing pediatric endocrinologist, even in an era when delivery of health care and research related to children and adolescents is being dramatically eroded." Dr. Oberfield has been engaged in patient-oriented research for her entire career, with a particular focus on disorders of adrenal hormone synthesis, adrenarche, and PCOS. She has conducted studies of body composition in children and continues to be involved in multiple studies of childhood obesity. Her clinical research has centered around the developmental/pediatric endocrinology, specifically the HPA axis which intimately affects metabolic function, interacting with adiposity, including studies of body composition in adrenarche and PCOS. She has been the author or co-author of more than 225 articles, multiple chapters and reviews, and is an invited speaker at national and international meetings, including the 2012 NIH-sponsored Evidence Based Methodology Workshop on Polycystic Ovary Syndrome. She is currently an editor for the Journal of Pediatrics and is an associate editor for Hormone Research in Pediatrics. She continues to be listed in Castle Connelly's "America's Top Doctors" and NY Magazine's "Best Doctors."

Biography: Dr. Bilezikian, the Dorothy L. and Daniel H. Silberberg Professor of Medicine and Professor of Pharmacology at the College of Physicians & Surgeons, Columbia University is Vice Chair of the Department of Medicine for International Education and Research and Chief, Emeritus, of the Division of Endocrinology. He is Director, Emeritus, of the Metabolic Bone Diseases Program at Columbia University Medical Center. Dr. Bilezikian received his undergraduate training at Harvard College and his medical training at the College of Physicians & Surgeons. He completed four years of house staff training (internship, residency and Chief Residency) on the Medical Service at Columbia Presbyterian Medical Center. Dr. Bilezikian received his training in Metabolic Bone Diseases and in Endocrinology at the National Institutes of Health in the Mineral Metabolism Branch under the tutelage of Dr. Gerald Aurbach. He belongs to a number of professional societies including the American Society of Bone and Mineral Research, of which he served as President (ASBMR), 1995-1996 and the International Society of Clinical Densitometry (ISCD), of which he served as President, 1999-2001. He is a member of the Endocrine Society, the American Federation for Clinical Research, the American Society for Clinical Investigation, the Association of American Physicians, the American Association of Clinical Endocrinologists, the American Society for Pharmacology and Experimental Therapeutics, and the American College of Endocrinology that has designated him Master. He served on the Board of Governors of the International Osteoporosis Foundation (1999-2015) and is a current member of its Committee of Scientific Advisors. He is Chair of the Endocrine Fellows Foundation. He served as Editor-in-Chief of the Journal of Clinical Endocrinology and Metabolism and as Senior Associate Editor of the Journal of Bone and Mineral Research. He is Executive Advisory Editor of Bone Research. His books include Editor-in-Chief of The Parathyroids [1994, 2001, 2015], and co-editor of The Aging Skeleton (1999), Dynamics of Bone and Cartilage Metabolism (1999, 2006), Principles of Bone Biology (1996, 2002, 2008, 2020) and Osteoporosis in Men (2010). He is Editor-in-Chief of the Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism (2019). He has been on numerous panels, including serving as Chair of the NIH Consensus Development Panel on Optimal Calcium Intake (1994), Co-chair of the last three International Workshops on Primary Hyperparathyroidism (2002, 2008, 2013) and of the first International Workshops on Hypoparathyroidism (2015) and Controversies in Vitamin D (2017, 2018, 2019). Dr. Bilezikian's major research interests are related to the clinical investigation of metabolic bone diseases, particularly primary hyperparathyroidism, hypoparathyroidism and osteoporosis. His studies of parathyroid hormone in these disorders with regard to etiology, clinical manifestations, pathophysiology, mechanisms of skeletal involvement, and therapy are known throughout the world as landmark contributions to our knowledge of these disorders. He has been continuously funded by the NIH since 1974. Over 850 publications speak to these active original investigative initiatives as well as his authorship of many reference sources of endocrinology and metabolic bone diseases. Dr. Bilezikian is the recipient of the Distinguished Physician Award of the Endocrine Society, the Frederic C. Bartter Award of the ASBMR for Excellence in Clinical Research, and the First Annual Global Leadership Award of the ISCD. In 2009, he received the Gideon A. Rodan Excellence in Mentorship Award from the ASBMR. He received the Laureate Distinguished Educator Award of the Endocrine Society in 2014. In 2014, he was made honorary member of the Brazilian Society of Endocrinology and Metabolism and the Association of Brazilian Orthopedic Osteologists. In 2015, he received the Oscar Gluck Humanitarian Award of the ISCD and the Inaugural Global Educator of the Year Award from McMaster University in Canada. In 2017, he was named Honorary Member of the Russian Osteoporosis Association. Dr. Bilezikian has received Lifetime Achievement and Recognition Awards of the California and Boston Armenian American Medical Societies and the Armenian American Health Professionals Organization (AAHPO). In 2017, he received the Doctor Honoris Causa Award from the Carol Davila School of Medicine in Bucharest, Romania and from the University of Pisa, in Pisa, Italy. He received the Distinguished Physician Award of the American Association of Clinical Endocrinologists in 2018. He received the Ellis Island Congressional Medal of Honor from the United States Government in 2018. Also, in 2018 he received a Parliamentary Medal of Honor from the Government of Armenia for distinguished service and a similar honor from the Government of Brazil. In 2019, he received the Gold Medal for Outstanding Achievements in Medical Research, the highest honor that Columbia University's College of Physicians and Surgeons bestows on its graduates. In 2020, Dr. Bilezikian received the ASBMR William F. Neuman Award for highest scientific achievement.

Biography: My interest in the physical and mental wellbeing of children and adolescents started in medical school and was solidified during my pediatric residency. I cared for underprivileged children and teenagers with growth failure, failure to thrive, and obesity. Those experiences led me to the field of pediatric endocrinology, which provided me with the opportunity to treat children of all ages with a wide spectrum of endocrine disorders. I have a special interest in growth and puberty disorders as well as the late endocrine effects of childhood cancer. My clinical academic background has helped me to build a unique practice in which I take care of very complex patients with endocrine disorders, including oncology patients, transplant patients, and international patients with complex endocrine disorders. My training in pediatric endocrinology and metabolism also sparked my interest in clinical research. In a study funded by the New York Empire Clinical Investigator Program I explored the metabolic effects on children exposed to diabetes in utero, and I also worked on the NIH Bone Mineral Density Childhood Project. Following these projects I had five years of rich experience working with Columbia's Center for Children's Environmental Health, exploring the effects of air pollution and endocrine disruptors on children's metabolism and their link to obesity. I have been lucky to share my experience and passion for endocrinology through teaching many pediatric endocrinology fellows, pediatric residents, and medical students. My goal as a physician is intertwined with my goal as an educatorteaching the new generation of physicians the art of pediatric medicine and endocrinology.

Care Philosophy: We are committed to delivering the best care and an exceptional patient experience. We are devoted to providing services that are patient-centered and compassionate, and care for you as a person.

Biography: Dr. Jacqueline Salas-Spiegel, MD is an Endocrinology, Diabetes /amp Metabolism Specialist who practices in New York, NY. She has been practicing for 39 years. Dr. Jacqueline Salas-Spiegel, MD is affiliated with Newyork-Presbyterian/Columbia University Medical Center.

Biography: I am a pediatric endocrinologist with interests that include polycysytic ovary syndrome (PCOS), bone health, disorders of puberty, thyroid disorders, pituitary disorders and growth disorders. In addition to my training in pediatrics and pediatric endocrinology, I have Master of Science degrees in Nutrition (1999) and in Patient Oriented Research (2014) and have completed a research fellowship at the Body Composition Unit of Columbia University Medical Center (2003). I comleted the TRANSFORM KL2 program sponsored by the Irving Institute of Clinical and Translational Research, a mentored career development program. My responsibilites include my clinical practice, overseeing clinical and research fellows, mentoring students, and running a clinical study. I have been certified as a clinical densitometrist by the International Society of Clinical Densitometry and interpret pediatric bone mineral density studies performed at Columbia University Irving Medical Center. My research project, "A double-blind placebo-controlled randomized clinical trial assessing the efficacy of metformin for hepatic fat in adolescents and young adults with polycystic ovary syndrome" has the primary goal of exploring the use of novel and noninvasive testing and a pilot double-blind placebo-controlled trial of metformin with the intention of identifying and potentially treating non-alcoholic fatty liver disease in adolescents and young adults with PCOS. My research is unique in that it uses minimally invasive body composition methodology, which makes it particularly attractive for use in adolescents and young adults. My overall clinical research goal is early identification and treatment of metabolic and body composition abnormalities associated with PCOS and to prevent lifelong morbidity associated with this disorder in a young population

Biography: Dr. Utpal Pajvani, Associate Professor of Medicine in the Division of Endocrinology at Columbia University, is a physician-scientist with clinical and research focus in Type 2 Diabetes and related metabolic diseases. He graduated from the Massachusetts Institute of Technology with a degree in Biology in 1996, then earned MS (2001), MD (2005) and PhD (Department of Cell Biology, 2005) degrees from the Albert Einstein College of Medicine. Dr. Pajvani completed his internship and residency training and is board certified in Internal Medicine (2007) and fellowship in Endocrinology, Diabetes & Metabolism (2011), both at the Columbia University Medical Center. Dr. Pajvani has been on the faculty of Columbia University since 2011. He is a teaching attending on the inpatient and outpatient Endocrinology and General Medicine services of the New York Presbyterian Hospital, and sees patients at the Naomi Berrie Diabetes Center at Columbia University.

Biography: Dr. Henry Ginsberg, MD is an Endocrinology, Diabetes /amp Metabolism Specialist who practices in New York, NY. He has been practicing for 30 years. Dr. Henry Ginsberg, MD is affiliated with Newyork-Presbyterian/Columbia University Medical Center.

Biography: Dr. Fennoy is a board certified pediatric endocrinologist with additional certification as a Physician Nutrition Specialist as well as an Obesity Medicine specialist. She received her Doctor of Medicine degree form the University of California, San Francisco and her Masters Degree in Public Health from Columbia University, School of Public Health. Her pediatric training was done in the Department of Social Pediatrics, Montefiore Hospital, Bronx, New York, Nutrition training at the Institute of Human Nutrition, Columbia University and Pediatric Endocrine training with the Pediatric Medicine Branch off the National Institute of Child Health, Bethesda, Maryland. She has focused much of her research on the comorbidities identified in morbidly obese children and adolescents as well as the impact bariatric surgery has on these problems. In addition, she has been involved in a school based study to evaluate the impact of a nutrition education curriculum and exercise program on the changes in insulin resistance in middle school children.

Biography: Dr. Magdalena Bogun, MD is an Endocrinology, Diabetes /amp Metabolism Specialist who practices in New York, NY. She has been practicing for 16 years. Dr. Magdalena Bogun, MD is affiliated with Newyork-Presbyterian/Columbia University Medical Center.

Biography: Dr. Blandine Laferrre, MD, PhD is an endocrinologist in clinical practice for over 30 years. She got her MD and a PhD in Human Biology in the University Claude Bernard in Lyon, France, did a residency in internal medicine and a fellowship in endocrinology both in France and in the United States, and a post-doctoral research fellowship at MIT in the field of neuropharmacology of appetite regulation.Dr. Laferrre is a Professor of Medicine at Columbia University. She is a clinical researcher and holds a part time general endocrine practice within the Endocrine Division at Columbia University Medical Center with a focus on metabolism, obesity, type 2 diabetes and thyroid. With continuous NIH funding since 1998, she studies the mechanism by which obesity can lead to type 2 diabetes and how various types of weight loss interventions can improve metabolism or even put diabetes in remission. She currently investigates the effect of time restricted eating and sleep on metabolism in adults with prediabetes. She is the site principal investigator of a multicenter study investigating the effect of prediabetes, diabetes and metformin on brain health. Dr. Laferrre has over 130 publications and book chapters, has a national and international reputation in the field of obesity and type 2 diabetes clinical research, and is a reviewer for many European and American grant agencies.

Biography: Dr. Mishaela Rubin is an Assistant Professor of Clinical Medicine. She attended Barnard College (1991) and Columbia University College of Physicians and Surgeons (1995), completing her Internal Medicine residency (1998) and Endocrinology fellowship training (2002) at Columbia University. Dr. Rubin also completed a Master's degree in Biostatistics at Columbia University (2006). She received an Endocrine Fellows Foundation Award (2001), a Mentored Patient-Oriented Research Career Development Award (K23, NIH 2004-2009), a Patient-Oriented Research Track Scholarship (K30, NIH, 2004-2006) and a Young Investigator Award from the American Society of Bone and Mineral Research (2006). Dr. Rubin also received an Irving Scholarship for Young Investigators at Columbia University (2008-2011) as well as a CTSA/CTO Pilot Award (2008).